News Hub | News Direct

Bumble’s 2024 Dating Trends

YourUpdateTV

Bumble, the women-first dating and social networking app, recently released its annual dating trends for 2024. The popular dating app garnered insights from more than 25,000 singles on Bumble around the world to identify trends that will define dating and relationships in the year to come. Recently, Bumble’s Sex and Relationships Expert, Shan Boodram, participated in a nationwide satellite media tour to discuss the trends and share tips on dating in 2024. A video accompanying this announcement is available at: https://youtu.be/tA1Q2D6PV6A Heading into 2024, there is an air of optimism and clarity for the ‘year of self’ as Bumble’s research shows that more than half (57%) of women surveyed are going into the new year with a clear view of what they want from their romantic lives. According to Bumble, this year will bring about: 1. Betterment Burnout: In recent years, we’ve seen a rise in ‘self-optimization’ which has led the majority of singles (55%) to feel pressure to constantly look for ways to better themselves, leaving 1 in 4 (24%) feeling unworthy of a partner. Looking ahead to 2024, singles are rebelling against the constant self-improvement with more than 2 in 3 women surveyed (68%) taking active steps to be happier with who they are here and now. 2. Timeline Decline: People, especially women, continue to feel a constant pressure to follow traditional relationship timelines. But in 2024, women are choosing to actively build their own path, with 1 in 3 (31%) women saying they are no longer focused on adhering to traditional timelines and milestones such as dating>marriage>kids. 3. Gen(erational)-Blend Romance: This year, people are doubling down on casting a wider net, age included. For 2 in 3 (63%) people, age is not a defining factor when dating with more than half (59%) of women saying they are now more open to dating someone younger than them. Below are some tips for those looking to kickstart their dating journey in 2024: ● Create a “to feel” list rather than a “to be/to have” list. Focusing on things you want a partner “to be” or “to have” like a specific height or a specific career can lead to a match that isn’t necessarily the kind, lasting connection you’re looking for. Instead, think about what you would put on your “To feel” list: ‘I want to feel safe, I want to feel respected, I want to feel protected.’ Creating this list can help you find and understand what is most important to you beyond physical attributes. ● Date smarter, not harder. In a recent Bumble survey, 1 in 4 U.S. daters shared that they feel short on time and want to make dating as efficient as possible. If you’re finding it hard to prioritize dating with your busy schedule - you’re not alone! Bumble’s data also shows that Monday between 7:00-8:00 pm is the most popular day and time on Bumble in the US. Capitalize on Bumble’s peak Monday time by using features that help you find more relevant potential partners, faster, like Bumble’s Advanced Filters feature, which allows you to filter for various values and lifestyle choices. ● Choose quality over quantity. Dating doesn’t have to be a numbers game. In fact, more than half (52%) of women recently surveyed about dating in 2024 said they are focusing on quality of dates over quantity. For more information, download the Bumble app via the App Store or Google Play. About Shan Boodram Shan Boodram is a certified sex educator, dating coach and intimacy expert. Boodram is host of the top podcast, "Lovers and Friends," the best-selling author of “The Game of Desire,” resident expert on Netflix's “Too Hot to Handle,” and host of The Marriage Pact on the Roku Channel. She is an ambassador for AIDS Healthcare Foundation and WomensHealth.gov, and a member of the American Sexual Health Association. She holds a Master’s degree in Psychology from Arizona State University, and currently resides in Los Angeles, California. About Bumble Bumble, the women-first dating and social networking app, was founded by Whitney Wolfe Herd in 2014. Bumble connects people across dating (Bumble Date), friendship (Bumble For Friends) and professional networking (Bumble Bizz). Bumble is built on the importance of equitable relationships and how crucial they are to a healthy, happy life. The app is built with a focus on kindness, respect, and equality – and the community plays an important part in that. Bumble holds its users accountable for their actions and strives to provide them with an experience free from hate, aggression, or bullying. The app is free to download and is widely available in the Apple App Store, Google Play Store and the web. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

February 09, 2024 11:42 AM Eastern Standard Time

Video

SingularityNET Arrives In Switzerland Counseled By STORM Partners — Uniting Artificial Intelligence & Decentralization

STORM Partners

Geneva, Switzerland, February 9, 2024 – SingularityNET (SNET), a global innovator within the decentralized artificial intelligence (AI) space, has established its Foundation in Switzerland through Geneva to the Crypto Valley in Zug. This strategic move underscores the SNET commitment to the decentralized, democratic values seen within its AI initiatives, including within its governance structure. The Zug-based Foundation will support the development of new use cases for the ecosystem, expand its global community, and promote research and development projects. Commenting on the move, SingularityNET Founder and CEO Ben Goertzel remarks: “The Foundation is set to further enable the Web3 vision of creating a decentralized and democratic paradigm that meets the challenges of the modern world. The move to Zug underlines our commitment to do this with the utmost transparency and highest standards of compliance.” Working in conjunction with STORM Partners, a Swiss Web3-focused professional services firm, SingularityNET has relocated its foundation from Amsterdam, in the Netherlands, to Zug, in Switzerland. Choosing Switzerland as the market from which to drive global adoption of the technology, as well as its more philosophical and ethical underpinnings, is also a nod to Switzerland’s reputation: a neutral and benign confederation that has been practising democracy since as early as the thirteenth century. It’s no wonder it’s also a hub of decentralization, disintermediation, and trust. “This strategic move highlights once more Switzerland's attraction for innovation. Clear guidelines for the digital economy mean Web3 entrepreneurs can benefit from the stability they so desperately require when venturing into this ever-changing field,” adds Sheraz Ahmed, Managing Partner of STORM Partners. Switzerland’s crypto-friendly regulatory framework and secure business environment are key drivers behind SNET’s decision to establish its Foundation in Zug. This move allows SNET to leverage Switzerland’s thriving crypto community ecosystem, fostering an environment of innovation, collaboration, and growth for its beneficial and compassionate AI vision. Zug’s Crypto Valley is home to +1,600 blockchain-based projects, including industry leaders like Ethereum, Polkadot, Tezos, and many more. SNET’s unique take on AI and commitment to developing a decentralized platform for artificial general intelligence (AGI) will add a new richness to the Zug community. SingularityNET works with partners like Cisco, Cardano, and Hanson Robotics, famous for the human Sophia the Robot. SNET’s mission to redefine the future of AI by building an AGI transcends the limitations of centralization, and ensures openness for all, free from the narrow objectives of a single corporation or nation. Now this bold mission is matched with a state-of-the-art governance structure that provides for future growth in a decentralized environment. About SingularityNET: SingularityNET is a pioneering decentralized AI platform that combines the power of blockchain technology with artificial intelligence. It envisions creating an inclusive, democratic, and beneficial AGI free from centralization, corporate control, and national restrictions. SNET’s core mission is to democratize AI, ensuring this technology benefits all humanity. About STORM Partners STORM Partners is a premier all-in-one professional services provider within the dynamic blockchain industry. Its expertise spans the global landscape of Web3, collaborating with a diverse spectrum of businesses and brands – from nimble startups and pre-IDOs to flourishing scale-ups and established global organizations. Contact Details Storm Partners Adrian Bono adrian.bono@storm.partners

February 09, 2024 10:14 AM Eastern Standard Time

Image

News Release

California Couple Loses Home Due to Blatant Bookkeeping Error by Specialized Loan Servicing, LLC

Law Office of Lorden and Reed

In a distressing incident highlighting the critical impact of administrative errors in mortgage servicing, a now-separated couple from Palmdale, California, has filed a multi-count lawsuit against Specialized Loan Servicing, LLC (SLS). The lawsuit, filed in California State Court, alleges breach of contract, theft, and several other counts, accusing SLS of negligence as the mortgage servicer added a quarter of a million dollars to the couple’s mortgage – leading to their financial and personal ruin. The couple is represented by the Law Office of Lorden and Reed. Michael L. Russell and Renita Y. Russell, the plaintiffs in this case, claim that SLS's incompetence and negligent bookkeeping forced them into bankruptcy and later to a short sale of their home. This resulted in a significant loss of equity, estimated to be in the hundreds of thousands of dollars, and severe emotional distress, which contributed to the dissolution of their over 20-year marriage. The Russells' story began in 2004 when they purchased a four-bedroom home in Palmdale. SLS took over the servicing of their loan in 2014. Following a loan modification in 2015, SLS erroneously added over a quarter of a million dollars to the loan balance. By 2018, SLS claimed the Russells were in default by $69,332, and by early 2019, the indebtedness purportedly reached a staggering $946,239. Despite their efforts, including filing for Chapter 13 bankruptcy and making consistent payments towards their mortgage, the couple's attempts to resolve the issue through legal counsel and requests for an accurate accounting from SLS were fruitless. The inflated loan balance led to a forced short sale in April 2022 to avoid foreclosure. A year later, SLS admitted they were wrong but refused to accept responsibility for their egregious actions. The consequences of SLS's actions have been devastating for the Russells. They lost approximately $300,000 in home equity and faced excessive housing costs, moving and storage expenses, attorney fees, and litigation costs. Moreover, they have endured severe mental and emotional distress, resulting in the breakdown of their marriage, significant damage to their credit, and the loss of their home. SLS, in their capacity as the mortgage servicer, was acting on behalf of Deutsche Bank National Trust Company. Last year, Rithm Capital Corp. announced it would acquire Computershare Mortgage Services Inc. and certain affiliated companies including Specialized Loan Servicing LLC. The lawsuit includes counts of breach of contract, negligence, negligent misrepresentation, intentional misrepresentation, unfair business practices, unfair debt collection, theft, and other counts. The Russells seeks restitution of all monies paid to SLS in excess of the actual amount owed, compensatory damages, and punitive damages. The Russells wish to hold SLS accountable for the irreparable harm caused by their alleged negligence and to warn others of the potential risks involved in mortgage servicing errors. Download a copy of the legal filings here and at LawsuitPressRelease.com. Contact Details JOHN P DAVID +1 305-255-0035 john@davidpr.com Company Website https://lorden-reed.com/

February 09, 2024 09:39 AM Eastern Standard Time

BestGrowthStocks.Com Interviews Dan O’Toole of Arrive Technology Inc.

Arrive Technology Inc.

NEW YORK, NY February 8th, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on growth stocks utilizing exclusive ai-assisted research recently issued a new CEO interview with Arrive Technology Inc’s Dan O’Toole. Steve Macalbry of BGS had the pleasure of recently conducting an Interview with Dan O’Toole of Arrive Technology Inc. (NASDAQ: BRSH). Steve diligently focused on questions he thought would be on the minds of most current and potential future shareholders. Interview Highlights: Best Growth Stocks Senior Editor Steve Macalbry and Dan O’Toole discuss the Arrive Technology business model, growth plans, post-merger priorities, long-term goals, leveraging AI and much more in this interview. Access this interview in its entirety at: https://bestgrowthstocks.com/bestgrowthstocks-com-interviews-arrive-technology-inc-nasdaq-brsh/ (copy and paste to browser may be required) Dan O’Toole, CEO Arrive Technology Inc. Chairman & Chief Executive Officer Access this interview in its entirety at: https://bestgrowthstocks.com/bestgrowthstocks-com-interviews-arrive-technology-inc-nasdaq-brsh/ (copy and paste to browser may be required) About Arrive technology Inc. Arrive specializes in secure automated cross-docking technology and Mailbox-as-a-Service (MaaS), unlocking the seamless movement of goods and supplies between people, robots, and drones. Empowering customers with tailored MaaS solutions to make it easier for them to scale and meet the demands of today's fast-paced world. Visit: https://www.arrive.tech/ About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Contact Details Best Growth Stocks Steve Macalbry Editor@bestgrowthstocks.com

February 09, 2024 09:35 AM Eastern Standard Time

Image

West Red Lake Gold (WRLG.V) Focused on Further Definition of Near-Term Mining Inventory

West Red Lake Gold Mines Ltd.

February 9, 2024 – TheNewswire – Global Stocks News – In a press release dated February 7, 2024, West Red Lake Gold Mines (TSXV:WRLG) (OTC:WRLGF) reported drill results from the North Austin Zone, which represents a new area of high-grade mineralization extending the current Madsen resource to the northeast. The company’s flagship asset - The Madsen Gold Mine – is debt free, fully permitted, with a brand-new 800+ tonne per day mill, a tailings and water treatment facility. [ 1 ] The Madsen Mine deposit presently hosts an NI 43-101 Indicated resource of 1.65 million ounces of gold grading 7.4 g/t Au and an Inferred resource of 0.37 Moz of gold grading 6.3 g/t Au. [2.] [3.] The current underground drilling program at the Madsen Mine is focused on definition of near-term mining inventory, as well as growth of the current mineral resource. Hole MM24X-03-5195-006 intercepted 8.12 g/t Au over 2 meters, suggesting vertical continuity of almost two full mine levels, or approximately 50 meters, below any workings at the East Portal. Additionally, holes MM24X-03-5195-001, -003 and -004 all intercepted high-grade mineralization beneath current workings effectively extending a known ore shoot approximately 25 meters down plunge. Click Image To View Full Size North Austin plan view drill section showing assay highlights for Holes MM24X-03-5195-001 through -010. [1] *Geologic domains and 2021 block model have not yet been updated to incorporate drill results in this press release. Plan section view is cut on a 60m-thick slice which may distort apparent thickness of the mineralized domains – refer to cross-section figures for more accurate representation of thickness. The WRLG team believes these intercepts are indicative of the resource growth potential that still exists at the Madsen Mine asset. The North Austin Zone sits adjacent to existing underground development marking it as a high caliber target that could potentially be developed early during future mine restart and production. The North Austin Zone remains open down-dip and along strike to the northeast and will continue to be a priority expansion target as underground drilling continues. HIGHLIGHTS: Hole MM24X-03-5195-003 Intersected 3.3m @ 9.15 g/t Au, from 148.7m to 152m, Including 1m @ 15.91 g/t Au, from 148.7m to 149.7m, also Including 0.7m @ 18.62 g/t Au, from 150.7m to 151.4m. Hole MM24X-03-5195-001 Intersected 2.6m @ 10.66 g/t Au, from 154.4m to 157m, Including 0.9m @ 18.35 g/t Au, from 155.4m to 156.3m. Hole MM24X-03-5195-006 Intersected 2.4m @ 8.12 g/t Au, from 85.3m to 87.7m. Hole MM24X-03-5195-004 Intersected 1.4m @ 10.55 g/t Au, from 141m to 142.4m. “This latest round of North Austin results are very encouraging and demonstrate the untapped growth potential that still exists in this part of the Madsen deposit,” stated Shane Williams, President & CEO of WRLG. Click Image To View Full Size “There are two types of drilling we are currently doing underground at Madsen,” VP of Exploration Will Robinson confirmed to Guy Bennett, CEO of Global Stocks News. “We have expansion drilling - which is what we just completed at North Austin. It’s growth oriented, drilled at a wider spacing, to define a larger area. We process that data, get the assays back. If the results are favorable, we then follow-up with definition drilling, using tighter spacing, to bring that gold into the mineable inventory category.” “That's the plan at North Austin,” Robinson continued. “Go back in and drill with tighter spacing to increase confidence in this area.” Click Image To View Full Size North Austin cross-section showing assay highlights for Hole MM24X-03-5195-006. [1] *Geologic domains and 2021 block model have not yet been updated to incorporate drill results in this press release. “The original geologic model that was used for mining by the previous operator did not capture the complexity of the Madsen deposit,” stated Robinson. “This resulted in excessive dilution during mining. The West Red Lake team now has a much more realistic geologic model and a proven workflow for accurately defining additional ounces. The current Madsen drill program, including the February 7, 2024 North Austin drill results, is feeding into that model and workflow.” “We are now approaching Madsen as an advanced stage exploration project with near term development potential,” Robinson continued. “Our objective for the 2024 drill program at Madsen is to build a +1 year runway of high confidence ounces for the mill restart, while also taking full advantage of near-mine, high-grade resource expansion opportunities.” “As we continue to advance the East Portal decline, we will be establishing additional drilling platforms to continue extending this zone at depth,” added WRLG CEO Shane Williams. References: SRK Consulting. (2021). Independent NI 43-101 Technical Report and Updated Mineral Resource Estimate for the PureGold Mine, Canada (West Red Lake Gold Mines, Ed.) [Review of Independent NI 43-101 Technical Report and Updated Mineral Resource Estimate for the PureGold Mine, Canada. Mineral resources are estimated at a cut-off grade of 3.38 g/t Au and a gold price of US1,800/oz. Please refer to the technical report entitled “Independent NI 43-101 Technical Report and Updated Mineral Resource Estimate for the PureGold Mine, Canada”, prepared by SRK Consulting (Canada) Inc. and dated June 16, 2023. A full copy of the SRK report is available on the Company’s website and on SEDAR+ at www.sedarplus.ca Mineral resources that are not mineral reserves do not have demonstrated economic viability. Please refer to the technical report entitled “Independent NI 43-101 Technical Report and Updated Mineral Resource Estimate for the PureGold Mine, Canada”, prepared by SRK Consulting (Canada) Inc. and dated June 16, 2023. The Madsen Resource Estimate has an effective date of December 31, 2021 and excludes depletion of mining activity during the period from January 1, 2022 to the mine closure on October 24, 2022 as it has been deemed immaterial and not relevant for the purpose of the updated report. A full copy of the SRK report is available on the Company’s website and on SEDAR+ at www.sedarplus.ca Contact: guy.bennett@globalstocksnews.com Full Disclaimer

February 09, 2024 09:00 AM Eastern Standard Time

Image

BlackRock Acquires Stake In Cardio Diagnostics

Cardio Diagnostics Holdings, Inc

By Jeremy Golden, Benzinga BlackRock (NYSE: BLK) has acquired a minor stake in Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company. In BlackRock’s 13G filing on Feb. 2, they disclosed ownership representing 5.2% of Cardio Diagnostics. Fintel reports that the average one-year price target for Cardio Diagnostics is $6.12, and forecasts range from a low of $4.04 to a high of $8.40. Cardio Diagnostics had Weighted-Average Shares Outstanding (Diluted) of 11.90 million for the most recently reported fiscal quarter, ending Sept. 30, 2023. Cardio Diagnostics’ stock has an ownership structure of institutional, retail and individual investors. About 1.84% of the company’s stock is owned by institutional investors, while 18.58% is owned by insiders. About 79.58% is owned by public companies and individual investors. Prelude Capital Management, Geode Capital Management and Vanguard Group are the biggest institutional shareholders, with 121,000, 75,483 and 64,022 shares, respectively. About Cardio Diagnostics Cardio Diagnostics was formed to develop and commercialize clinical tests that leverage artificial intelligence-driven technology to combat cardiovascular disease. The company is behind PrecisionCHD, the first integrated genetic-epigenetic test for the detection of coronary heart disease (CHD), the most common type of heart disease and the cause of most heart attacks. With the introduction of PrecisionCHD, clinicians are armed with a powerful, scalable and non-invasive alternative that comes in the form of a blood-based test that uses artificial intelligence (AI), along with personalized genetic and epigenetic information, to sensitively detect the presence of CHD. Cardio Diagnostics has also developed Epi+Gen CHD, a powerful test that predicts the three-year risk for a CHD event, mainly a heart attack. Powered by AI-driven integrated genetics and epigenetics, the tool enables more effective decision-making and earlier interventions. Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine (“Core Technology”) for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit www.cardiodiagnosticsinc.com. Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases “will”, "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," “goal,” or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company’s ability to compete, regulatory matters, protection of technology, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Current Report on Form 10-K for the period ended December 31, 2022 and Form 10-Q for the period ended March 31, 2023, under the heading “Risk Factors” in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Gene Mannheimer - Investor Relations +1 855-226-9991 investors@cardiodiagnosticsinc.com Company Website https://cardiodiagnosticsinc.com/

February 09, 2024 08:30 AM Eastern Standard Time

Geoff Reiss, Former GM of Yahoo Sports, Named Chairman of StreamLayer

StreamLayer

StreamLayer, a leader in the monetization of live OTT sports content, has appointed Geoff Reiss, the former GM of Yahoo Sports, as the company’s new chairman. Reiss, who also served as Head of Sports at Twitter and CEO of the Professional Bowlers Association, has an extensive record of leading groundbreaking sports media businesses, including his role in launching ESPN.com and ESPN's fantasy platform. As StreamLayer experiences a surge in demand for its video monetization technology, Reiss's timing couldn't be more opportune. The company's technology is increasingly sought after for its ability to unlock new revenue sources and attract younger audiences, a necessity as the industry undergoes a difficult transition from linear TV to streaming. StreamLayer is also planning to unveil a groundbreaking event-triggered, in-game advertising solution later this year, and Reiss will play a key role in its introduction to the market. "We're honored to have Geoff on board,” said John Ganschow, StreamLayer CEO. “His expertise in commercialization and partnership development will be invaluable as we tap into these new opportunities and expand our global reach across the sports media sector." “StreamLayer is at the forefront of developing new and incredibly exciting ways for fans to engage with live sports, and I couldn’t be more excited for the opportunity to help them become a fixture within the industry,” said Reiss. About StreamLayer: StreamLayer is revolutionizing the economic model for OTT providers around the globe. The Company’s proprietary Video Engagement Operating System (VEOS) enables content programmers and broadcast rights holders to transform linear streaming video feeds into highly monetizable interactive viewing experiences, seamlessly integrated into their own native app environments to facilitate valuable first-party data collection. StreamLayer is headquartered in Chicago, IL. Contact Details StreamLayer John Ganschow +1 312-543-0488 john@streamlayer.io Company Website https://www.streamlayer.io/

February 09, 2024 07:00 AM Central Standard Time

Image

Financial Gravity Welcomes Announces Profitability Milestone in Q4 2023

Financial Gravity Companies, Inc.

Financial Gravity Companies, Inc. (OTC: FGCO) (“Financial Gravity”), a leading financial services provider, announced today that it achieved profitability for the first time in the quarter ending December 31, 2023, marking an important milestone for the company. "We are thrilled to have reached profitability last quarter," said Scott Winters, CEO of Financial Gravity. "Our strategic growth initiatives and focus on operational efficiency have driven improved financial performance. We intend to build on this momentum in 2024 and beyond." Financial Gravity has reached this significant profitability milestone due to the successful execution of our long-term growth strategy over the past few years. Key achievements that have fueled the path to profitability include: the acquisition and integration of Trusted Advisor/Trusted Team LLC, Marathon Financial Group, LLC, and Cambridge Cape Cod Advisors that expanded our client base in New Mexico, Ohio, Massachusetts, and Florida; development of technology that has enhanced our client experience and back-end systems; double-digit revenue growth from the prior year. These efforts have not only expanded the company’s market reach but have also enhanced its product and service offerings, enabling it to better serve its growing client base. Winters reiterated Financial Gravity's commitment to creating long-term value for its shareholders: "Today's announcement reinforces the strength of our business model and growth strategy. We will maintain our balanced approach to maintain our growth momentum. Financial Gravity's latest financial statements and disclosures are available through the OTC Markets website. Our company profile page can be accessed at www.otcmarkets.com under the stock ticker symbol 'FGCO' or by searching our company name. This provides our regulatory filings, historical annual and quarterly reports, officer/director information, and performance. See the 'Disclosure and News' tab on our company's OTC profile. Investors can view our full financial results including income statements, balance sheets, and statements of cash flows. About Financial Gravity Companies, Inc. Financial Gravity Companies Inc., along with its subsidiary companies, provides investment and tax professionals with a turnkey family office charter. We help tax professionals evolve from the commoditized business of tax compliance to a Family Office Director that runs and manages their own multi-family office. Family Office Directors are able to leverage the Financial Gravity systems, technology, proprietary resources, and deep domain expertise to bring an elevated and holistic financial service experience to their clients that spans proactive tax planning, retirement and estate planning, wealth management, and risk mitigation. For more information about Financial Gravity Companies, Inc., please visit https://financialgravity.com. Forward-Looking Statements This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert, or change any of them and could cause actual outcomes and results to differ materially from the current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Financial Gravity's business, and Financial Gravity undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Contact Details Financial Gravity Companies, Inc. Scott Winters +1 800-588-3893 scott.winters@financialgravity.com Company Website https://financialgravity.com/

February 09, 2024 06:00 AM Eastern Standard Time

News Release

CapitalGainsReport Sector Spotlight: Orthobiologics Watchlist (ORHB, ZBH, GMED, SYK)

ORHB- Orthobiologics

Orthobiologics represents a dynamic field within healthcare where the body's natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies signify a significant evolution in medical treatment, offering promising solutions for patients worldwide. The global orthobiologics market is experiencing substantial growth, with projections exceeding US$6.5 billion by 2022 and maintaining a steady CAGR of 5.9% until 2030. Various factors fuel this growth, including demographic shifts with an aging population, an increase in spine abnormalities, and advancements in stem cell research. Companies actively drive innovation through developing bone graft substitutes and minimally invasive procedures, expanding the market's reach and impact. Let's explore the profiles of four key players actively driving innovation and shaping the future of orthobiologics: HippoFi (OTC: ORHB) is a company that is expanding its presence in the healthcare industry, fueled by cutting-edge technology and an innovative approach to medicine. The company's unwavering dedication to delivering groundbreaking healthcare solutions is evident through its focused efforts on pioneering first-to-market solutions across the multibillion-dollar biotech, fintech, and AI sectors. At the heart of HippoFi's success lies its suite of proprietary technologies meticulously crafted to address critical medical needs and enhance patient outcomes. Anchoring its operations is PUR Biologics, the company's regenerative therapeutics division, committed to developing and deploying scalable biological solutions within the $1.37 trillion biotechnology market. HippoFi's portfolio encompasses advanced allografts and demineralized extracellular matrices (d-ECM), representing groundbreaking advancements in tissue regeneration and repair. These innovative solutions offer a holistic approach to healing, aiming to restore function and mobility to patients grappling with degenerative conditions. Moreover, HippoFi's synthetic bone-forming solutions and cellular-derived tissues signify significant milestones in orthopedic care. By harnessing the power of regenerative stem cells and growth factors, HippoFi is at the forefront of pioneering next-generation therapeutics for treating osteoarthritis and facilitating cartilage regeneration. What sets HippoFi apart is its commitment to personalized medicine, leveraging biotech and AI technologies to develop tailored treatments for individual patient needs. Through strategic partnerships with industry leaders such as ZIMMER BIOMET and Hoag Hospital Newport Beach, HippoFi is spearheading innovation in spine care solutions, revolutionizing the delivery of spinal biologics. The recent acquisition of activeOrb technology further solidifies HippoFi's position as a leader in the regenerative therapeutics market. This cutting-edge technology enhances HippoFi's capabilities in bone-growth solutions, reaffirming its commitment to advancing healthcare technologies and solutions. On January 23, 2024, HippoFi's (OTC: ORHB) biotechnology arm, PUR Biologics, proudly announced Scott Bauccio as its new Head of Sales. Leveraging his 20 years of sales management and extensive network of industry-leading professionals, Bauccio is expanding the company's sales and distribution channels. Already securing two new products, PURamnio (available now) and PURpeptide (launching within 30 days), Bauccio's appointment underscores HippoFi's strategic focus on growth and market expansion. "We are excited to welcome Scott to our team. His proven success in driving growth and remarkable ability to establish a strong market presence are perfectly aligned with our objectives," says Ryan Fernan, Head of PUR Biologics. CJ Wiggins, Executive Chairman and CEO of HippoFi, shared, "Scott's appointment is a tactical move to strengthen our leadership team at a pivotal time in our sales growth. His industry expertise and market insights are invaluable in our continuous pursuit of innovation and excellence in the biologic sector." During his tenure as the Vice President of Sales & Business Development at Biogennix, Bauccio successfully established the company's ortho-spine biologic sales and distribution channels throughout the United States. His appointment reflects the first of several strategic actions HippoFi will take in 2024 to further their commitment to leading the industry as the authority in regenerative biologics. In summary, HippoFi's proprietary technologies, strategic partnerships, and exponential growth trajectory position it as a trailblazer in the healthcare sector. By harnessing the power of biotech and AI, HippoFi is spearheading transformative treatments that have the potential to revolutionize patient care and drive significant value for shareholders. Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands at the forefront of medical technology, specializing in orthopedic reconstructive products. With over 90 years of experience, the company continues to drive innovation and shape the future of orthopedic care. In the third quarter of 2023, Zimmer Biomet reported impressive financial results, with a 5.0% increase in net sales, reaching $1.754 billion. These figures underscore the company's financial strength and resilience in a rapidly evolving healthcare landscape. Key to Zimmer Biomet's success is its commitment to strategic leadership changes. The appointment of CEO Ivan Tornos reflects a dedication to innovation and commercial execution, positioning the company for continued growth. Further leadership updates, including the expanded role of CFO Suketu Upadhyay, demonstrate Zimmer Biomet's proactive approach to driving excellence in orthopedic healthcare. Zimmer Biomet's commitment to innovation is demonstrated by milestones such as enrolling 100,000 patients in the MyMobility care management system. This platform integrates automation, data, and insights to enhance the orthopedic patient experience, underscoring Zimmer Biomet's commitment to improving outcomes and patient satisfaction. Recognized for its Environmental, Social, and Governance (ESG) initiatives, Zimmer Biomet has earned accolades such as inclusion on the Newsweek America's Greenest Companies 2024 list and the Sustainability Magazine Top 10: Sustainable Healthcare Device Companies. Furthermore, Zimmer Biomet's commitment to delivering value to shareholders is evident in its approval of a quarterly cash dividend of $0.24 per share for Q4 2023, reinforcing its dedication to shareholder returns and long-term sustainability. Globus Medical, Inc. (NYSE: GMED) has been a pioneering force in medical technology since its founding in 2003. The company's core mission is to develop innovative products that empower surgeons to enhance healing in patients with musculoskeletal disorders. Globus Medical has a market capitalization of $6.81 billion and is poised for growth, owing primarily to the success of its U.S. spine and trauma portfolios. Despite encountering macroeconomic challenges affecting profit margins, the company has experienced a noteworthy 31.2% stock increase over the past year. With a long-term estimated earnings growth rate of 11.5%, slightly below the industry average of 13.3%, GMED has consistently outperformed earnings estimates, delivering an average surprise of 5.44% in the last four quarters. In terms of strategic upsides, GMED reported a 10.7% increase in musculoskeletal revenues in the third quarter. This success is attributed to the launch of innovative products like REFLECT, MARVEL, and Ossifuse, with expectations of a robust series of product launches throughout the Musculoskeletal portfolio in 2024. The company continues to prioritize product development, as evidenced by the September 2023 launch of the Precice Bone Transport system, Hydrone, and the Strato trauma wiring system. Surgeons can expect to have access to a growing number of options, including a 3D-printed interbody portfolio, cervical discs, robotic prone and lateral systems, EGPS E3D, neuromonitoring solutions, retractors, and limb-lengthening products. Financially resilient, GMED ended Q3 2023 with $468.9 million in cash and short-term marketable securities, showcasing strong liquidity, solvency, and a debt-free balance sheet. In recent developments, Globus Medical, Inc. announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2023. The company anticipates fourth-quarter 2023 sales of approximately $615.5 million, an increase of 124.2 percent over the fourth quarter 2022 on an as-reported basis. Full-year 2023 sales are expected to be approximately $1.567 billion, an increase of 53.2 percent over the prior year on an as-reported basis. Dan Scavilla, president and CEO of Globus Medical, highlighted the monumental year, including the completion of a merger with NuVasive to create the most innovative technology company in the spine market. Revenue for the full year and fourth quarter of 2023 set new records, indicating significant progress in U.S. Spine and Enabling Technologies. Looking ahead, Globus Medical is focused on delivering product innovation, superior customer service, and operational excellence to advance patient care. The company's trajectory of product launches and advancements positions it for sustained growth and impact in the medical device industry. Keith Pfeil, CFO of Globus Medical, emphasized the company's strong finish in Q4 and its overall full-year performance, outlining objectives for 2024, including sales growth, continued merger integration activities, and realizing synergy capture. The company established a full-year 2024 revenue guidance range of $2.450 billion to $2.475 billion and a fully diluted non-GAAP earnings per share range of $2.68 to $2.70. Stryker Corporation (NYSE: SYK) is a leader in medical technology with a global focus, committed to improving healthcare outcomes across the board. With an extensive portfolio spanning medical and surgical, neurotechnology, orthopedics, and spine, the company impacts over 130 million patients annually. The company, headquartered in Kalamazoo, Michigan, specializes in MedSurg, neurotechnology, orthopedics, and spine solutions. Stryker's commitment to innovation and improving healthcare outcomes is evident in its extensive product portfolio and continuous advancements in spine-related technology. Under the leadership of Robbie Robinson, President of the Spine division, Stryker's Spine business has experienced significant growth. The introduction of innovative products like the Q Guidance System with Spine Guidance Software has been recognized with industry awards, demonstrating Stryker's dedication to surgical spine planning and navigation. Key products like the Monterey AL Interbody System, incorporating Tritanium In-Growth Technology, and the OmniCurve curved balloon system further exemplify Stryker's commitment to enhancing surgical capabilities and patient outcomes. In January 2024, Stryker announced its fourth-quarter earnings, reporting profits of $1.14 billion. Earnings per share were $2.98, with adjusted earnings of $3.46 per share, exceeding Wall Street expectations. The company's revenue for the quarter stood at $5.82 billion, surpassing analysts' forecasts. For the full year 2023, Stryker reported a profit of $3.17 billion, or $8.25 per share, with total revenue reaching $20.5 billion. Looking ahead, Stryker expects full-year earnings in the range of $11.70 to $12 per share, demonstrating confidence in its future growth trajectory. Stryker's exceptional financial performance, coupled with its continuous innovation in spine-related technology, positions the company as a major player in the medical device sector and underscores its potential for sustained success. Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, or assumptions of future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. Capital Gains Report (CGR), owned by RazorPitch Inc., is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR has been retained by HippoFi Inc to produce and distribute this content. As part of that content, readers, subscribers, and webs are expected to read the full disclaimers and financial disclosure statement that can be found on our website capitalgainsreport.com All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR is not a fiduciary by virtue of any persons use of or access to this content. Contact Details Mark McKelvie +1 585-301-7700 markrmckelvie@gmail.com Company Website http://CapitalGainsReport.com

February 09, 2024 05:15 AM Eastern Standard Time

All Industries

Bumble’s 2024 Dating Trends

SingularityNET Arrives In Switzerland Counseled By STORM Partners — Uniting Artificial Intelligence & Decentralization

California Couple Loses Home Due to Blatant Bookkeeping Error by Specialized Loan Servicing, LLC

BestGrowthStocks.Com Interviews Dan O’Toole of Arrive Technology Inc.

West Red Lake Gold (WRLG.V) Focused on Further Definition of Near-Term Mining Inventory

BlackRock Acquires Stake In Cardio Diagnostics

Geoff Reiss, Former GM of Yahoo Sports, Named Chairman of StreamLayer

Financial Gravity Welcomes Announces Profitability Milestone in Q4 2023

CapitalGainsReport Sector Spotlight: Orthobiologics Watchlist (ORHB, ZBH, GMED, SYK)